[Damages to the anterior eye segment by drugs].
D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000925:Anticoagulants / Q000009:adverse effects; D000928:Antidepressive Agents / Q000009:adverse effects; D003315:Cornea; D004140:Dinitrophenols / Q000009:adverse effects; D064420:Drug-Related Side Effects and Adverse Reactions; D004837:Epinephrine / Q000009:adverse effects; D005128:Eye Diseases / Q000139:chemically induced*; D005938:Glucocorticoids / Q000009:adverse effects; D006046:Gold / Q000009:adverse effects; D006801:Humans; D006827:Hydantoins / Q000009:adverse effects; D007065:Idoxuridine / Q000009:adverse effects; D007637:Keratoconjunctivitis / Q000139:chemically induced; D008916:Miotics / Q000009:adverse effects; D010615:Phenacetin / Q000009:adverse effects; D010640:Phenothiazines / Q000009:adverse effects; D012163:Retinal Detachment / Q000139:chemically induced; D012835:Silver Nitrate / Q000009:adverse effects; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced; D013449:Sulfonamides / Q000009:adverse effects; D013792:Thalidomide / Q000009:adverse effects; D014786:Vision Disorders / Q000139:chemically induced
D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D000928:Antidepressive Agents; D004140:Dinitrophenols; D005938:Glucocorticoids; D006827:Hydantoins; D008916:Miotics; D010640:Phenothiazines; D013449:Sulfonamides; D013792:Thalidomide; D006046:Gold; D012835:Silver Nitrate; D010615:Phenacetin; D007065:Idoxuridine; D004837:Epinephrine
Schädigungen des vorderen Augenabschnittes durch Medikamente.